Baxter International Inc.

NYSE:BAX Voorraadrapport

Marktkapitalisatie: US$16.7b

Baxter International Toekomstige groei

Future criteriumcontroles 3/6

De omzet van Baxter International zal naar verwachting dalen met 2.4% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 39.8% per jaar. De winst per aandeel zal naar verwachting groeien met 41.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13% zijn.

Belangrijke informatie

39.8%

Groei van de winst

41.8%

Groei van de winst per aandeel

Medical Equipment winstgroei17.0%
Inkomstengroei-2.4%
Toekomstig rendement op eigen vermogen13.0%
Dekking van analisten

Good

Laatst bijgewerkt20 Nov 2024

Recente toekomstige groei-updates

Recent updates

Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Sep 05
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Aug 07
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Jul 23
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Jul 12
Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

May 30
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

May 14
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Apr 14
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Feb 20
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Jan 28
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Jan 12
Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Dec 28
Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Nov 27
Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Is Baxter International (NYSE:BAX) A Risky Investment?

Oct 27
Is Baxter International (NYSE:BAX) A Risky Investment?

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Sep 21
There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Aug 23
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Dividend Challengers Review: Baxter International

Aug 14

Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Jul 25
Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Jul 14
Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF

Jun 12

Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Jun 07
Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

May 19
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Winst- en omzetgroeiprognoses

NYSE:BAX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202611,7749151,3771,9278
12/31/202511,2636869521,47610
12/31/202410,5562771,2271,9269
9/30/202415,0621213911,062N/A
6/30/202414,962985181,174N/A
3/31/202414,892-387071,410N/A
12/31/202314,813-761,0341,726N/A
9/30/202311,379961,1081,634N/A
6/30/202312,389-2,9328881,559N/A
3/31/202314,461-2,6738371,482N/A
12/31/202214,506-2,6665911,211N/A
9/30/202214,275-2,5687921,465N/A
6/30/202213,8928761,1591,850N/A
3/31/202213,3969921,3412,053N/A
12/31/202112,1461,0221,5312,222N/A
9/30/202112,4511,2141,4962,241N/A
6/30/202112,1971,1201,3542,076N/A
3/31/202111,8171,0681,2651,973N/A
12/31/202011,6731,1021,1591,868N/A
9/30/202011,5319111,2361,985N/A
6/30/202011,4109241,4162,176N/A
3/31/202011,5269911,4872,248N/A
12/31/201911,3621,0011,4082,104N/A
9/30/201911,1561,3351,2011,984N/A
6/30/201911,0661,4849811,739N/A
3/31/201911,0601,5059291,698N/A
12/31/201811,0991,5521,2862,017N/A
9/30/201811,0631,0651,0201,699N/A
6/30/201811,009795N/A1,848N/A
3/31/201810,763840N/A2,095N/A
12/31/201710,584609N/A1,714N/A
9/30/201710,4321,025N/A2,036N/A
6/30/201710,283904N/A1,963N/A
3/31/201710,2631,852N/A2,176N/A
12/31/201610,1634,966N/A1,654N/A
9/30/201610,1214,909N/A1,665N/A
6/30/201610,0504,784N/A1,388N/A
3/31/20169,9403,646N/A1,342N/A
12/31/20159,968393N/A1,771N/A
9/30/201510,154337N/A2,190N/A
6/30/201510,376510N/A2,849N/A
3/31/20159,27484N/A2,752N/A
12/31/201410,719457N/A3,215N/A
9/30/201412,252739N/A3,155N/A
6/30/201413,2531,092N/A3,207N/A
3/31/201415,3671,967N/A3,371N/A
12/31/20139,413315N/A3,198N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei BAX ( 39.8% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van BAX ( 39.8% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).

Hoge groeiwinsten: De winst van BAX zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van BAX zal naar verwachting de komende 3 jaar dalen ( -2.4% per jaar).

Hoge groei-inkomsten: De omzet van BAX zal naar verwachting de komende 3 jaar dalen ( -2.4% per jaar).


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen BAX zal naar verwachting over 3 jaar laag zijn ( 13 %).


Ontdek groeibedrijven